Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Commitments, Significant Contracts and Contingencies

Commitments, Significant Contracts and Contingencies

3 Months Ended

Nov. 30, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments, Significant Contracts and Contingencies

17. Commitments, Significant Contracts and Contingencies

Management and Service Agreements:

As at November 30, 2019, the Company is party to the following contractual commitments:

Party	Monthly Commitment	Expiry Date
C.A.B Financial Services	CAD $29,167	January 1, 2022
Docherty Management Ltd.	CAD $25,000	January 1, 2022
ME Services Ltd.	CAD $12,960	June 1, 2021
Corporate development	CAD $1,000	Month to Month
Corporate development	CAD $8,000	Month to Month
Investor relations and communications – Alex Blanchard Capital	CAD $7,500	Month to Month
Office management	CAD $10,000	August 15, 2022
Research development	CAD $3,854	Month to Month
Office rent⁽¹⁾	CAD $4,823	November 15, 2023

Corporate Offices

⁽¹⁾Corporate office and RD lab space leased in Kelowna, British Columbia, Canada until November 15, 2023 with an option to extend an additional five years.